Cantor Fitzgerald analyst Pete Stavropoulos initiated coverage of Alector with an Overweight rating and $13 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALEC:
- Alector completes enrollment in Phase 2 trial of Alzheimer’s candidate AL002
- Unicycive Therapeutics appoints Sara Kenkare-Mitra to board of directors
- Alector to Participate in Upcoming Healthcare Conferences
- Alector price target lowered to $10 from $12 at Mizuho
- Alector price target lowered to $8 from $10 at Stifel